AI Article Synopsis
- Cellulomonas spp. are typically considered low-risk for causing human infections, but this case presents the first known instance of endocarditis linked to this bacteria in an intravenous drug user.
- The diagnosis of infective endocarditis was confirmed through established Duke criteria, highlighting the severity of the infection.
- The patient faced complications, including heart failure and a possible mycotic aneurysm, ultimately requiring aortic valve replacement after finishing antimicrobial treatment.
Article Abstract
Cellulomonas spp. are often believed to be of low virulence. There are only a few reports of human infections. We report the first case of endocarditis caused by Cellulomonas in an intravenous drug abuser. The diagnosis of infective endocarditis (IE) in this case was definite using the Duke criteria. The course of the disease was complicated with a heart failure and possible mycotic aneurysm in the left leg. After the end of antimicrobial therapy aortic valve replacement was done because of severe heart failure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00508-013-0367-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mortality Profile of Deaths Related to Infective Endocarditis in Brazil and Regions: A Population-Based Analysis of Death Records.
Trop Med Infect Dis
November 2024
Department of Specialized Medicine-Cardiology Discipline, School of Medicine and Surgery, Federal University of the State of Rio de Janeiro, Rua Silva Ramos, 32, Tijuca, Rio de Janeiro 20270-330, Brazil.
Background: Studies of infective endocarditis (IE) are generally limited to institutions, underlining the need for more comprehensive epidemiological research.
Objective: The aim of this study was to determine the mortality profile of IE-related deaths and related causes in Brazil at the national level and across regions.
Method: We conducted a population-based study using data from the country's mortality information system for the period 2000 to 2019.
Role of Multimodal Imaging in Clinical Practice for the Diagnosis of Infective Endocarditis: A Case Series.
Infect Dis Rep
December 2024
Infectious Diseases Clinic, Santa Maria della Misericordia Hospital, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Background: The 2023 European Society of Cardiology (ESC) guidelines for the management of infective endocarditis (IE) highlighted the essential role of multimodal imaging in the diagnostic algorithm of IE and its complications.
Methods: We hereby report a case series of IE in which the diagnosis was confirmed or excluded by the use of multimodal imaging during the period between January 2024 and July 2024 at the Infectious Diseases Clinic, Perugia Hospital, Italy.
Results: Six patients were retrospectively included.
Impact of Hospital Lead Extraction Volume on Management of Cardiac Implantable Electronic Device-Associated Infective Endocarditis.
Europace
December 2024
Department of Medicine, Division of Cardiology, Weill Cornell Medicine - New York Presbyterian Hospital and Weill Cornell Cardiovascular Outcomes Research Group (CORG), New York, NY.
Background: Utilization of transvenous lead extraction/removal (TLE) for the management of cardiac implantable electronic device (CIED)-associated infective endocarditis (IE) remains low.
Objective: To examine the impact of hospital TLE procedural volume on TLE utilization and outcomes for patients with CIED-associated IE.
Methods: Using the Nationwide Readmissions Database, we evaluated 21,545 admissions for patients (mean age 70, 39% female) with CIEDs hospitalized with IE at TLE centres.
Similar but Distinct-Biochemical Characterization of the Staphylococcus aureus Serine Hydrolases FphH and FphI.
Proteins
December 2024
Ilse Katz Institute for Nanoscale Science and Technology (IKI), Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Staphylococcus aureus is a major cause of infections like bacteremia, pneumonia, and endocarditis. These infections are often linked to the ability of S. aureus to form biofilms.
View Article and Find Full Text PDFThe dark side of the fibroblastic sleeve: Case report and literature review.
J Vasc Access
December 2024
Clinical Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
The fibroblastic sleeve is a structure potentially enveloping any intravascular device. At ultrasound scan, it typically presents as a thin layer of variably echogenic material covering the catheter surface, which usually tends to remain into the vessel after the catheter removal. However, several case reports have documented its migration toward the heart or pulmonary artery after a central venous catheter removal.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!